Position in INCY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$36,114,682
+$1,793,166 QoQ
Shares Held
318,584
-12.6% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#81
of 854 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $101,442,658 across 6 Biotechnology names. INCY ranks #2 (35.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
74,200 | $46,266,668 | |
| 2 | INCY |
Incyte Corp
This page
|
318,584 | $36,114,682 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
137,395 | $18,236,438 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
10,891 | $396,541 | |
| 5 | ALT |
Altimmune, Inc.
|
83,837 | $254,864 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
28,344 | $173,465 |
All Filings in INCY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,114,682 | 318,584 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $34,321,516 | 364,657 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $29,269,995 | 296,345 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,104,374 | 248,843 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $20,813,947 | 305,638 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $24,745,695 | 408,682 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $31,475,129 | 455,699 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $38,407,999 | 581,059 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $35,505,861 | 585,712 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $29,900,533 | 524,847 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $33,915,390 | 540,140 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $29,249,644 | 506,312 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $26,182,972 | 420,610 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $30,967,695 | 428,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $34,537,600 | 430,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $24,890,040 | 373,500 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $29,180,077 | 384,100 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $30,386,092 | 382,600 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $23,488,000 | 320,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,788,586 | 98,700 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||